Victoria "Tori" Gemme MS, MBA

Victoria “Tori” Gemme is an Assistant Research Director for the Biomedical Innovation team. She works with the medical products development and regulations team, specifically leading the Institute's FDA PDUFA cooperative agreement work. Over her time at Duke-Margolis, Victoria has worked on projects spanning a range of topics including rare disease drug development, prescription drug promotion regulation, development and regulation of psychedelics for therapeutic use, hepatitis C elimination, and value-based payment approaches for medical products among other topics.

Prior to joining Duke-Margolis, Victoria was a senior specialist at the Cystic Fibrosis Foundation, where she oversaw a wide-ranging policy portfolio covering basic science research, drug development, antimicrobial resistance, and organ transplant among other topics. Victoria graduated from Vassar College with a bachelor’s degree in neuroscience, from Suffolk University with a master’s in ethics and public policy, and from Quantic School of Business and Technology with a master’s in business administration.